David Baker
70Patents
8h-index
133Co-inventors
81Inventor score
Filing activity: May 17, 1976 → Jun 20, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8187855B2 | Large-scale production of soluble hyaluronidase | Chemistry; Metallurgy | 52 | Active |
| US8343487B2 | Large-scale production of soluble hyaluronidase | Chemistry; Metallurgy | 44 | Active |
| US6046228A | Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof | Chemistry; Metallurgy | 19 | Expired |
| US4048432A | 9-(3,5-Di-O-acyl-.beta.-D-arabinofuranosyl)adenine compounds and method for their production | Human Necessities | 13 | Expired |
| US9630994B2 | Polypeptides for use in self-assembling protein nanostructures | Chemistry; Metallurgy | 9 | Active |
| US8969521B2 | General method for designing self-assembling protein nanomaterials | Physics | 9 | Active |
| US4055717A | 9-(3-O-Acyl-.beta.-D-arabinofuranosyl)adenine compounds, 9-(2,3-di-O-acyl-.beta.-D-arabinofuranosyl)-adenine compounds, and method for their production | Chemistry; Metallurgy | 8 | Expired |
| US5843990A | Pyran-chromenone compounds, their synthesis and anti-HIV activity | Chemistry; Metallurgy | 8 | Expired |
| US8340951B2 | Synthetic enzymes derived from computational design | Physics | 7 | Active |
| US7250298B2 | Monomeric red fluorescent proteins | Emerging Cross-Sectional Technologies | 6 | Expired |
| US10351603B2 | Polypeptides for use in self-assembling protein nanostructures | Chemistry; Metallurgy | 6 | Active |
| US10844105B2 | De novo design of potent and selective interleukin mimetics | Emerging Cross-Sectional Technologies | 5 | Active |
| US10703791B2 | De novo design of potent and selective interleukin mimetics | Emerging Cross-Sectional Technologies | 5 | Active |
| US4055718A | 9-(2-O-Acyl-.beta.-D-arabinofuranosyl)-adenine compounds and method for their production | Chemistry; Metallurgy | 5 | Expired |
| US7910714B2 | Monomeric red fluorescent proteins | Emerging Cross-Sectional Technologies | 4 | Active |
| US11117944B2 | De novo design of potent and selective interleukin mimetics | Emerging Cross-Sectional Technologies | 4 | Active |
| US7574306B1 | Method and system for optimization of polymer sequences to produce polymers with stable, 3-dimensional conformations | Physics | 4 | Expired |
| US11028383B2 | Polypeptide assemblies and methods for the production thereof | Chemistry; Metallurgy | 4 | Active |
| US4069382A | 9-(5-O-Acyl-.beta.-D-arabinofuranosyl)adenine compounds | Human Necessities | 4 | Expired |
| US11142577B2 | WNT signaling agonist molecules | Chemistry; Metallurgy | 3 | Active |
| US5608085A | Synthesis of optically active calanolides A and B and enantiomers and related compounds | Chemistry; Metallurgy | 3 | Expired |
| US4117229A | 2-Amino-1-(5-amino-1H-imidazol-4-yl)ethanone and method of preparation | Chemistry; Metallurgy | 3 | Expired |
| US4195176A | Imidazole compounds, methods for their production and conversion of said compounds into (R)-3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz ol[4,5-d][1,3]diazepin-8-ol | Chemistry; Metallurgy | 3 | Expired |
| US6353112B1 | Sultams: Solid phase and other synthesis of anti-HIV compounds and compositions | Chemistry; Metallurgy | 3 | Expired |
| US7671185B2 | Monomeric red fluorescent proteins | Emerging Cross-Sectional Technologies | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.